Cardiology Headline News

Disruptions in endothelial function caused by brief bouts of elicited anger may be an early predictor of heart disease, but the underlying mechanism remains unclear, researchers reported.

ATLANTA — Obicetrapib, a novel cholesteryl ester transfer protein inhibitor, reduced atherogenic lipoprotein particles alone or in combination with ezetimibe, according to new data from the ROSE2 trial.

In the rapidly evolving landscape of investments, it is crucial for physicians to stay informed about alternative asset classes, such as cryptocurrency.

Monthly olezarsen 80 mg significantly lowered triglyceride levels and also reduced incidence of acute pancreatitis vs. placebo in patients with familial chylomicronemia syndrome, according to a study in The New England Journal of Medicine.

BOSTON — In this video, an expert talks about screening for CVD prior to exercise in several populations, as well as different approaches to activity restriction after a CVD diagnosis.

BOSTON — Aspirin may not be as beneficial vs. other agents for primary CVD prevention following recent research, according to a speaker at the ACP Internal Medicine Meeting.

Those who live in rural areas face a higher risk for dying early from preventable deaths, but primary care providers can implement strategies to reduce these disparities, experts said during a CDC press conference.

ATLANTA — IVUS-guided angioplasty was superior to an angiography-guided approach for improving immediate procedural outcomes and 12-month patency in patients with symptomatic femoropopliteal artery disease, a speaker reported.

ATLANTA — For patients with nonobstructive hypertrophic cardiomyopathy, ninerafaxstat, a novel cardiac mitotrope, safely improved HF symptoms during a 12-week period vs. placebo, a speaker reported.

Black adolescents who face more racial discrimination may be more likely to have metabolic syndrome at age 31 years, according to findings published in JAMA Network Open.